Hims & Hers Health (HIMS) Other Non Operating Income (2020 - 2026)
Hims & Hers Health's (HIMS) quarterly Other Non Operating Income came in at $4.1 million in Q1 2026, up 57.81% year-on-year from $2.6 million in Q1 2025, and down 35.52% quarter-over-quarter from $6.4 million in Q4 2025.
Hims & Hers Health (HIMS) Other Non Operating Income (2020 - 2026) Analysis & Trends
Hims & Hers Health has disclosed Other Non Operating Income across 7 years of filings, most recently posting $4.1 million for Q1 2026.
- Other Non Operating Income for Q1 2026 came in at $4.1 million, up 57.81% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.1 million (up 112.99% YoY), and the FY2025 annual result was $23.1 million, up 135.82% from the prior year.
- Other Non Operating Income came in at $4.1 million for Q1 2026 at Hims & Hers Health, down from $6.4 million in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $8.0 million in Q3 2025 to a low of $320000.0 in Q1 2022.
- The 5-year median for Other Non Operating Income is $2.3 million (2023), against an average of $2.7 million.
- Across the five-year window, Other Non Operating Income jumped 1115.2% in 2022 and tumbled 45.24% in 2024, its largest moves.
- Hims & Hers Health's Other Non Operating Income stood at $1.5 million in 2022, then soared by 72.15% to $2.6 million in 2023, then surged by 41.3% to $3.7 million in 2024, then soared by 72.1% to $6.4 million in 2025, then plunged by 35.52% to $4.1 million in 2026.
- The last three Other Non Operating Income figures came in at $4.1 million (Q1 2026), $6.4 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.10 Mn |
| Dec 31, 2025 | 6.36 Mn |
| Sep 30, 2025 | 8.04 Mn |
| Mar 31, 2025 | 2.60 Mn |
| Dec 31, 2024 | 3.70 Mn |
| Sep 30, 2024 | 1.22 Mn |
| Jun 30, 2024 | 2.39 Mn |
| Mar 31, 2024 | 2.50 Mn |
| Dec 31, 2023 | 2.62 Mn |
| Sep 30, 2023 | 2.23 Mn |
| Jun 30, 2023 | 2.24 Mn |
| Mar 31, 2023 | 1.88 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | 677,000.00 |
| Jun 30, 2022 | 402,000.00 |
| Mar 31, 2022 | 320,000.00 |
| Dec 31, 2021 | 125,000.00 |
| Sep 30, 2021 | 219,000.00 |
| Jun 30, 2021 | 325,000.00 |
| Mar 31, 2021 | -224,000.00 |